In fact, chemotherapy may induce CXCR4 upregulation in some AML cell lines and patient samples, which results in chemotaxis and stromal protection from additional chemotherapy-induced apoptosis (Sison et al., 2013). The gene discussed is CXCR4; the disease is acute myeloid leukemia.